Viloria K, Nasteska D, Briant LJ, Heising S, Larner DP, Fine NH, Ashford FB, da Silva Xavier G, Ramos MJ, Hasib A, Cuozzo F, Fox JEM, MacDonald PE, Akerman I, Lavery GG, Flaxman C, Morgan NG, Richardson SJ, Hewison M and Hondson DJ (2020) Vitamin-D-Binding Protein Contributes to the Maintenance of α Cell Function and Glucagon Secretion. Cell reports 31(11):107761.
Hasib A (2020) Multiagonist Unimolecular Peptides for Obesity and Type 2 Diabetes: Current Advances and Future Directions.
Clinical Medicine Insights: Endocrinology and Diabetes 13, p.1179551420905844.
Hasib A, Hennayake CK, Bracy DP, Bugler-Lamb AR, Lantier L, Khan F, Ashford MLJA, McCrimmon RJ, Wasserman DH and Kang L (2019) CD44 contributes to hyaluronan-mediated insulin resistance in skeletal muscle of high fat-fed C57BL/6 mice. American Journal of Physiology-Endocrinology and Metabolism 317(6):E973-83.
Khan D, Kelsey R, Maheshwari RR, Stone VM, Hasib A, Koivula FN, Watson A, Harkin S, Irwin N, Shaw JA, McClenaghan NH, Venglovecz V, Ébert A, Flodström-Tullberg M, White MG and Kelly K (2019) Short-term CFTR inhibition reduces islet area in C57BL/6 mice. Scientific reports 9(1):1-1.
Hasib A, Khan D, Craig SL, Gault VA, Flatt PR and Irwin N (2019) Antidiabetic effects and sustained metabolic benefits of sub-chronic co-administration of exendin-4/gastrin and xenin-8-Gln in high fat fed mice. European Journal of Pharmacology 865:172733.
Hasib A, Ng MT, Tanday N, Craig SL, Gault VA, Flatt PR and Irwin N (2019) Exendin‐4 (Lys27PAL)/gastrin/xenin‐8‐Gln: A novel acylated GLP‐1/gastrin/xenin hybrid peptide that improves metabolic status in obese‐diabetic (ob/ob) mice. Diabetes/metabolism research and reviews 35(3):e3106.
Hasib A, Ng MT, Khan D, Gault VA, Flatt PR and Irwin N (2018) Characterisation and antidiabetic utility of a novel hybrid peptide, exendin-4/gastrin/xenin-8-Gln. European journal of pharmacology 834:126-35.
Hasib A, Ng MT, Khan D, Gault VA, Flatt PR and Irwin N (2018) A novel GLP-1/xenin hybrid peptide improves glucose homeostasis, circulating lipids and restores GIP sensitivity in high fat fed mice. Peptides 100:202-11.
Hasib A, Ng MT, Gault VA, Khan D, Parthsarathy V, Flatt PR and Irwin N (2017) An enzymatically stable GIP/xenin hybrid peptide restores GIP sensitivity, enhances beta cell function and improves glucose homeostasis in high-fat-fed mice. Diabetologia, 60(3), pp.541-552.
Parthsarathy V, Irwin N, Hasib A, Martin CM, McClean S, Bhat VK, Ng MT, Flatt PR and Gault VA (2016) A novel chemically modified analogue of xenin-25 exhibits improved glucose-lowering and insulin-releasing properties. Biochimica et Biophysica Acta (BBA)-General Subjects 1860(4), pp.757-764.
View all publications in research portal